The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
Open accessAbstract
We report the identities of the members of a group of proteins that associate with BRCA1 to form a large complex that we have named BASC (B RCA1-a ssociated genome s urveillance c omplex). This complex includes tumor suppressors and DNA damage repair proteins MSH2, MSH6, MLH1, ATM, BLM, and the RAD50–MRE11–NBS1 protein complex. In addition, DNA replication factor C (RFC), a protein complex that facilitates the loading of PCNA onto DNA, is also part of BASC. We find that BRCA1, the BLM helicase, and the RAD50–MRE11–NBS1 complex colocalize to large nuclear foci that contain PCNA when cells are treated with agents that interfere with DNA synthesis. The association of BRCA1 with MSH2 and MSH6, which are required for transcription-coupled repair, provides a possible explanation for the role of BRCA1 in this pathway. Strikingly, all members of this complex have roles in recognition of abnormal DNA structures or damaged DNA, suggesting that BASC may serve as a sensor for DNA damage. Several of these proteins also have roles in DNA replication-associated repair. Collectively, these results suggest that BRCA1 may function as a coordinator of multiple activities required for maintenance of genomic integrity during the process of DNA replication and point to a central role for BRCA1 in DNA repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to ATM, the members of the BASC include the mismatch repair proteins, MLH1, MSH2, and MSH6, the Bloom's syndrome helicase (BLM), and the Mre11-Rad50-NBS1 complex.”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Wang et al. 2000
In the citing paper
“Recent findings position ATM and ATR as critical upstream modulators of the breast cancer susceptibility protein, BRCA1”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Wang et al. 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
The Bloom's syndrome gene product is homologous to RecQ helicases
Ellis, N. A., Groden, J. L., Ye, T.-Z., Straughen, J. E., Lennon, D. J., Ciocci, S., Proytcheva, M. A., & GERMAN, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90105-1 · Cited by 1,385
BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., & Miki, Y. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,378
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
Flagged first, then by citations
2 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,000
Constitutive DNA damage is linked to DNA replication abnormalities in Bloom's syndrome cells
Rassool, F. V., North, P. S., Mufti, G. J., & Hickson, I. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206970 · Cited by 37
BRCA1 is a novel regulator of metabolic function in skeletal muscle
Jackson, K. C., Gidlund, E., Norrbom, J., Valencia, A. P., Thomson, D. M., Schuh, R. A., Neufer, P. D., & Spangenburg, E. E. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m043851 · Cited by 38
Proteolysis of the Mismatch Repair Protein MLH1 by Caspase-3 Promotes DNA Damage-induced Apoptosis
Chen, F., Arseven, O. K., & Cryns, V. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400971200 · Cited by 37
Min, B., Weinert, B. T., & Rio, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403000101 · Cited by 37
An Activation Force-based Affinity Measure for Analyzing Complex Networks
Guo, J. H., Guo, H., & Wang, Z. (2011) · Scientific Reports · doi:10.1038/srep00113 · Cited by 36
Kononenko, A. V., Bansal, R., Lee, N., Grimes, B. R., Masumoto, H., Earnshaw, W. C., Larionov, V., & Kouprina, N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku870 · Cited by 36
Chen, L., Zhang, Y., Zhang, Z., Huang, T., & Cai, Y. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.06.007 · Cited by 36
Understanding Germ-Line Mutations inBRCA1
Szabo, C. I., Worley, T., & Monteiro, Á. N. A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.841 · Cited by 37
p53 Monitors Replication Fork Regression by Binding to “Chickenfoot” Intermediates
Subramanian, D., & Griffith, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506348200 · Cited by 36
Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells
Acharya, S. K., Kaul, Z., Gocha, A. R. S., Martinez, A. R., Harris, J. M., Parvin, J. D., & Groden, J. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103819 · Cited by 40
Rebbeck, T. R., Mitra, N., Domchek, S. M., Wan, F., Chuai, S., Friebel, T. M., Panossian, S., Spurdle, A. B., Chenevix‐Trench, G., kConFab, et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0625 · Cited by 36
Vlachostergios, P. J., Patrikidou, A., Daliani, D., & Papandreou, C. N. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00824.x · Cited by 36
Dutertre, S., Sekhri, R., Tintignac, L. A. J., Onclercq, R., Chatton, B., Jaulin, C., & Amor-Guéret, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105735200 · Cited by 36
Lane, T. F. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.843 · Cited by 36
Itakura, E., Sawada, I., & Matsuura, A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-05-0427 · Cited by 35
Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population
An, Y., Jin, G., Wang, H., Wang, Y., Liu, H., Li, R., Wang, H., Qian, J., Sun, W., Wang, Y., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.08.003 · Cited by 35
Self-citationThe Role of Ku70 as a Cytosolic DNA Sensor in Innate Immunity and Beyond
Sui, H., Hao, M., Chang, W., & Imamichi, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.761983 · Cited by 36
Bannister, L., Waldman, B. C., & Waldman, A. S. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.01.001 · Cited by 36
Vlček, D., Ševčovičová, A., Sviežená, B., Gálová, E., & Miadoková, E. (2007) · Current Genetics · doi:10.1007/s00294-007-0163-9 · Cited by 35
Unwinding protein complexes in ALTernative telomere maintenance
Bhattacharyya, S., Sandy, A., & Groden, J. L. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22388 · Cited by 37
Hironaka, K., Factor, V. M., Calvisi, D. F., Conner, E. A., & Thorgeirsson, S. S. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000067483.89649.11 · Cited by 35
Scientists and clinicians test their metal–back to the future with platinum compounds
Guminski, A. D., Harnett, P. R., & DeFazio, A. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00733-7 · Cited by 34
Lynch-like Syndrome: Potential Mechanisms and Management
Martínez‐Roca, A., Giner-Calabuig, M., Murcia, Ó., Castillejo, A., Soto, J. L., García‐Heredia, A., & Jover, R. (2022) · Cancers · doi:10.3390/cancers14051115 · Cited by 35
Clique-based data mining for related genes in a biomedical database
Matsunaga, T., Yonemori, C., Tomita, E., & Muramatsu, M. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-205 · Cited by 34
Tamborero, D., López-Bigas, N., & González-Pérez, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055489 · Cited by 34
Wiltshire, T. D., Senft, J., Wang, Y., Konat, G. W., Wenger, S. L., Reed, E., & Wang, W. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029504 · Cited by 34
Self-citationBRCA1—A good predictive marker of drug sensitivity in breast cancer treatment?
Mullan, P. B., Gorski, J. J., & Harkin, D. P. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.07.001 · Cited by 34
Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer
Young, L. C., Listgarten, J., Trotter, M. J., Andrew, S. E., & Tron, V. A. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08249.x · Cited by 34
Goldberg, M., Rummelt, C., Foja, S., Holbach, L., & Ballhausen, W. G. (2006) · Human Mutation · doi:10.1002/humu.20281 · Cited by 34
Down-Regulation of BRCA1 in Chronic Pancreatitis and Sporadic Pancreatic Adenocarcinoma
Beger, C., Ramadani, M., Meyer, S., Leder, G. H., Krüger, M., Welte, K., Gansauge, F., & Beger, H. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0992-3 · Cited by 34
Santarosa, M., Col, L. D., Tonin, E., Caragnano, A., Viel, A., & Maestro, R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0951 · Cited by 33
Beard, P. M., Griffiths, S. J., Gonzalez, O., Haga, I. R., Jowers, T. P., Reynolds, D. K., Wildenhain, J., Tekotte, H., Auer, M., Tyers, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098431 · Cited by 33
Mechanism and significance of chromosome damage repair by homologous recombination
Kawale, A. S., & Sung, P. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190093 · Cited by 33
BRCA1 modulates the expression of hnRNPA2B1 and KHSRP
Santarosa, M., Col, L. D., Viel, A., Bivi, N., DˈAmbrosio, C., Scaloni, A., Tell, G., & Maestro, R. (2010) · Cell Cycle · doi:10.4161/cc.9.23.14022 · Cited by 33
Evidence for a direct association of hMRE11 with the human mismatch repair protein hMLH1
Her, C. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00079-4 · Cited by 33
Novel consensus DNA‐binding sequence for BRCA1 protein complexes
Cable, P., Wilson, C., Calzone, F. J., Rauscher, F. J., Scully, R., Livingston, D. M., Li, L., Blackwell, C. B., Futreal, P. A., & Afshari, C. A. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10148 · Cited by 33
Chakraborty, U., George, C. M., Lyndaker, A. M., & Alani, E. (2015) · Genetics · doi:10.1534/genetics.115.184093 · Cited by 33
ATM in breast and brain tumors: a comprehensive review
Mehrdad, A. E., & Mehdipour, P. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0022 · Cited by 34
Hümmerich, J., Werle‐Schneider, G., Popanda, O., Celebi, O., Chang-Claude, J., Kropp, S., Mayer, C., Debus, J., Bartsch, H., & Schmezer, P. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000600883302 · Cited by 33
BRCA1 Activates a G2-M Cell Cycle Checkpoint following 6-Thioguanine–Induced DNA Mismatch Damage
Yamane, K., Schupp, J. E., & Kinsella, T. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2205 · Cited by 33
HDAC Inhibitors: A New Radiosensitizer for Non-small-cell Lung Cancer
Zhu, L., Wu, K., Ma, S., & Zhang, S. (2015) · Tumori Journal · doi:10.5301/tj.5000347 · Cited by 32
BRCA1 and BRCA2 Gene Expression: Diurnal Variability and Influence of Shift Work
Bracci, M., Ciarapica, V., Elexpuru-Zabaleta, M., Tartaglione, M. F., Pirozzi, S., Giuliani, L., Piva, F., Valentino, M., Ledda, C., Rapisarda, V., et al. (2019) · Cancers · doi:10.3390/cancers11081146 · Cited by 32
Rb-Associated Protein 46 (RbAp46) Inhibits Transcriptional Transactivation Mediated by BRCA1
Chen, G.-C., Guan, L., Yu, J., Li, G., Kim, H.-R. C., & Wang, Z. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5003 · Cited by 32
Isoflavones are safe compounds for therapeutical applications – Evaluation ofin vitrodata
Reiter, E., Reiter, E., Beck, V., Medjakovic, S., & Jungbauer, A. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802596461 · Cited by 32
Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines
Alhamdani, M. S. S., Youns, M., Buchholz, M., Gress, T. M., Beckers, M., Maréchal, D., Bauer, A. S., Schröder, C., & Hoheisel, J. D. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.04.042 · Cited by 34
Pichierri, P., & Franchitto, A. (2004) · BioEssays · doi:10.1002/bies.10411 · Cited by 32
Yoshida, Y., Tsunoda, T., Doi, K., Fujimoto, T., Tanaka, Y., Ota, T., Ogawa, M., Matsuzaki, H., Kuroki, M., Iwasaki, A., et al. (2012) · PubMed · Cited by 32
Deyssenroth, M. A., Terry, M. B., Delgado‐Cruzata, L., Liao, Y., & Santella, R. M. (2016) · Anticancer Research · doi:10.21873/anticanres.10987 · Cited by 32
Powerful tools for the characterization of protein complexes
Bauer, A., & Küster, B. (2003) · Cited by 32
Molecular biology and genetics of breast cancer development: A clinical perspective
Buchholz, T. A., & Wazer, D. E. (2002) · Seminars in Radiation Oncology · doi:10.1053/srao.2002.35248 · Cited by 32
Gene expression in the mouse preimplantation embryo
Stanton, J. L., Macgregor, A. B., & Green, D. P. L. (2003) · Reproduction · doi:10.1530/rep.0.1250457 · Cited by 32
Deficiency in SNM1 Abolishes an Early Mitotic Checkpoint Induced by Spindle Stress
Akhter, S., Richie, C. T., Deng, J. M., Brey, E. M., Zhang, X., Patrick, C., Behringer, R. R., & Legerski, R. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10448-10455.2004 · Cited by 32
Deficient Regulation of DNA Double-strand Break Repair in Fanconi Anemia Fibroblasts
Donahue, S. L., Lundberg, R., Saplis, R., & Campbell, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213251200 · Cited by 32
Immune Checkpoint Blockade in Breast Cancer Therapy
Bu, X., Yao, Y., & Li, X. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_18 · Cited by 31
Smith, J. A., Waldman, B. C., & Waldman, A. S. (2005) · Genetics · doi:10.1534/genetics.104.039362 · Cited by 32
Yeast Screens Identify the RNA Polymerase II CTD and SPT5 as Relevant Targets of BRCA1 Interaction
Bennett, C. B., Westmoreland, T. J., Verrier, C. S., Blanchette, C., Winsor, T. S., Phatnani, H. P., Mishina, Y. V., Hüper, G., Selim, A. L., Madison, E. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001448 · Cited by 33
Lokesh, G. L.-R., Rachamallu, A., Kumar, G. D. K., & Natarajan, A. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.01.025 · Cited by 32
WRN Loss Induces Switching of Telomerase-Independent Mechanisms of Telomere Elongation
Gocha, A. R. S., Acharya, S., & Groden, J. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093991 · Cited by 32
Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis
Rajan, A., Nadhan, R., Latha, N. R., Krishnan, N., Warrier, A. V., & Srinivas, P. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188482 · Cited by 30
BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy
Choi, E. A., Mun, G., Lee, J., Lee, H., Cho, J., & Lee, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114090 · Cited by 34
Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology
Kumar, V., Bauer, C., & Stewart, J. H. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151338 · Cited by 33
Analysis of the ERK1,2 transcriptome in mammary epithelial cells
Grill, C. J., Gheyas, F., Dayananth, P., Jin, W., Ding, W., Ping, Q. I. U., Wang, L., Doll, R. J., & English, J. M. (2004) · Biochemical Journal · doi:10.1042/bj20031688 · Cited by 30
The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors
Winter, S. L., Bosnoyan-Collins, L., Pinnaduwage, D., & Andrulis, I. L. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-85 · Cited by 30
Transcription-coupled repair of oxidative DNA damage in human cells: \nMechanisms and consequences
Tsutakawa, S. E., & Cooper, P. K. (2001) · eScholarship (California Digital Library) · Cited by 31
Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair
Cantor, S. B., & Xie, J. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20568 · Cited by 29
NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review
Berardinelli, F., di Masi, A., & Antoccia, A. (2013) · Current Genomics · doi:10.2174/13892029113146660012 · Cited by 30
Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients
Knopf, A., Lempart, J., Baş, M., Slotta‐Huspenina, J., Mansour, N., & Fritsche, M. K. (2015) · Oncotarget · doi:10.18632/oncotarget.2850 · Cited by 29
BRCA1 Forms a Functional Complex with γ ‐H2AX as a Late Response to Genotoxic Stress
Krum, S. A., Dalugdugan, E. D. L. R., Miranda‐Carboni, G. A., & Lane, T. F. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/801594 · Cited by 32
BRCA1: a scaffold for p53 response?
Hohenstein, P., & Giles, R. H. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00193-8 · Cited by 29
Role of c-Abl Kinase in DNA Mismatch Repair-dependent G2 Cell Cycle Checkpoint Arrest Responses
Wagner, M. W., Li, L. S., Morales, J. C., Galindo, C. L., Garner, H. R., Bornmann, W. G., & Boothman, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709953200 · Cited by 29
Patidar, P. L., Motea, E. A., Fattah, F. J., Zhou, Y., Morales, J. C., Xie, Y., Garner, H. R., & Boothman, D. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1492 · Cited by 29
Zhou, C., Huang, P., & Liu, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.197 · Cited by 29
Roads Leading to Breast Cancer
Haber, D. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432111 · Cited by 29
ATM in oral carcinogenesis: association with clinicopathological features
He, Y., Chen, Q., & Li, B. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0365-7 · Cited by 28
A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair Deficiencies
Zhang, Y., Fox, J. T., Park, Y.-U., Elliott, G., Rai, G., Cai, M., Sakamuru, S., Huang, R., Xia, M., Lee, K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2974 · Cited by 28
Ando, K., Shah, A. K., Sachdev, V., Kleinstiver, B. P., Taylor‐Parker, J., Welch, M. M., Hu, Y., Salgia, R., White, F. M., Parvin, J. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16376 · Cited by 28
The Fanconi anemia pathway and the DNA interstrand cross-links repair
Rosselli, F. (2003) · Biochimie · doi:10.1016/j.biochi.2003.11.002 · Cited by 28
Structural Studies of DNA End Detection and Resection in Homologous RecombinationPreprint
Schiller, C. B., Seifert, F. U., Linke, C., & Hopfner, K. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a017962 · Cited by 29
Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target
Goyal, G., Fan, T., & Silberstein, P. T. (2016) · Familial Cancer · doi:10.1007/s10689-016-9883-7 · Cited by 28
Breitkopf, S. B., Yuan, M., Helenius, K., Lyssiotis, C. A., & Asara, J. M. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03040 · Cited by 27
Morphological and pathological features of basal-like breast cancer
Botti, G., Cantile, M., Collina, F., Cerrone, M., Sarno, S., Anniciello, A., & Bonito, M. D. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.06.50 · Cited by 27
Restle, A., Janz, C., & Wiesmüller, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208639 · Cited by 27
RecQ helicases; at the crossroad of genome replication, repair, and recombination
Rezazadeh, S. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1243-y · Cited by 28
BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far
Sharma, B., Kaur, R. P., Raut, S., & Munshi, A. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.01.001 · Cited by 31
BLM Potentiates c-Jun Degradation and Alters Its Function as an Oncogenic Transcription Factor
Priyadarshini, R., Hussain, M., Attri, P., Kaur, E., Tripathi, V., Priya, S., Dhapola, P., Saha, D., Madhavan, V., Chowdhury, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.101 · Cited by 27
Hill, D. A., de la Serna, I. L., Veal, T. M., & Imbalzano, A. N. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20003 · Cited by 27
Simeone, A., Deng, C., Kelloff, G. J., Steele, V. E., Johnson, M. M., & Tari, A. M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi038 · Cited by 27
The role of RecQ helicases in non-homologous end-joining
Keijzers, G., Maynard, S., Shamanna, R. A., Rasmussen, L. J., Croteau, D. L., & Bohr, V. A. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.942450 · Cited by 26
LEDGF/p75 Is Required for an Efficient DNA Damage Response
Liedtke, V., Schröder, C., Roggenbuck, D., Weiss, R., Stohwasser, R., Schierack, P., Rödiger, S., & Schenk, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115866 · Cited by 26
The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
Miklikova, S., Trnkova, L., Plavá, J., Boháč, M., Kuniaková, M., & Cihova, M. (2021) · Cancers · doi:10.3390/cancers13030575 · Cited by 27
Serine–Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint
Fukasawa, T., Enomoto, A., & Miyagawa, K. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.013 · Cited by 26
Promising molecular targets in ovarian cancer
Blagden, S. P., & Gabra, H. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832eab1f · Cited by 26
Non-Bloom syndrome-associated partial and total loss-of-function variants of BLM helicase
Mirzaei, H., & Schmidt, K. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210304109 · Cited by 26
Alternative recombination pathways in UV-irradiated XP variant cells
Limoli, C. L., Giedzinski, E., & Cleaver, J. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208515 · Cited by 26
Molecular Pathogenesis of Fanconi Anemia
Collins, N. B., & Kupfer, G. M. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05108 · Cited by 26
Tapia, T., Sánchez, A., Vallejos, M., Álvarez, C., Moraga, M. L., Smalley, S. V., Mauricio Camus, A., Alvarez, M. G., & Carvallo, P. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9544-5 · Cited by 27
Kaplan, E., & Gündüz, U. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.09.002 · Cited by 26
Yan, Y., Black, C. P., Cao, P. T., Haferbier, J. L., Kolb, R. H., Spieker, R. S., Ristow, A. M., & Cowan, K. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5818 · Cited by 26
Ensuring the Stability of the Genome: DNA Damage Checkpoints
Latif, C., Harvey, S. H., & O'Connell, S. J. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.297 · Cited by 26
DNA mismatch repair efficiency and fidelity are elevated during DNA synthesis in human cells
Edelbrock, M. A., Kaliyaperumal, S., & Williams, K. J. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.006 · Cited by 26
Metadata
- Authors
- Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J.
- Affiliations
- New York Blood Center (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-04-15
- Volume
- 14
- Issue
- 8
- Pages
- 927-939
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316544
- OpenAlex
- W2127566231
- Cited by
- 1,221
- References
- 54
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 16 · 2022: 21 · 2021: 27 · 2020: 20 · 2019: 26 · 2018: 20 · 2017: 24 · 2016: 29 · 2015: 33 · 2014: 49 · 2013: 43 · 2012: 35
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Jane Coffin Childs Memorial Fund for Medical Research
- U.S. Bureau of Land Management
- U.S. Public Health Service (Q1187)
- National Institute of General Medical Sciences (GM-44664, R37GM044664, R01GM044664)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, BASC, DNA repair, MSH2, MSH6, MLH1, ATM, BLM helicase, PCNA, DNA damage recognition, genome stability, tumor suppressor proteins, nuclear foci
- MeSH terms
- Adenosine Triphosphatases, Cell Cycle, Cell Nucleus, DNA Repair, DNA Helicases, DNA-Binding Proteins, Endodeoxyribonucleases, Exodeoxyribonucleases, Fluorescent Antibody Technique, Fungal Proteins, HeLa Cells, Humans, Nuclear Proteins, Precipitin Tests, Protein Binding, Mass Spectrometry, Transcription, Genetic, Signal Transduction, Cell Cycle Proteins, BRCA1 Protein, Saccharomyces cerevisiae Proteins, Replication Protein C, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review